Victory Capital Management Inc Neogenomics Inc Transaction History

Victory Capital Management Inc

  • $153 Billion
  • Q3 2025

A detailed history of Victory Capital Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 18,278 shares of NEO stock, worth $188,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,278
Previous 23,487 22.18%
Holding current value
$188,994
Previous $171,000 17.54%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$4.84 - $8.81 $25,211 - $45,891
-5,209 Reduced 22.18%
18,278 $141,000
Q2 2025

Aug 13, 2025
SELL
$6.4 - $10.27 $1,036 - $1,663
-162 Reduced 0.69%
23,487 $171,000
Q1 2025

May 02, 2025
SELL
$9.09 - $18.61 $3,436 - $7,034
-378 Reduced 1.57%
23,649 $224,000
Q4 2024

Feb 06, 2025
SELL
$13.0 - $18.43 $4,888 - $6,929
-376 Reduced 1.54%
24,027 $395,000
Q3 2024

Nov 05, 2024
SELL
$13.4 - $17.73 $27,751 - $36,718
-2,071 Reduced 7.82%
24,403 $359,000
Q2 2024

Aug 05, 2024
SELL
$13.01 - $15.77 $4,137 - $5,014
-318 Reduced 1.19%
26,474 $367,000
Q1 2024

May 03, 2024
SELL
$14.06 - $16.79 $335,176 - $400,256
-23,839 Reduced 47.08%
26,792 $421,000
Q4 2023

Feb 05, 2024
BUY
$11.67 - $20.73 $5,799 - $10,302
497 Added 0.99%
50,631 $819,000
Q3 2023

Nov 06, 2023
BUY
$12.15 - $17.85 $345,521 - $507,618
28,438 Added 131.07%
50,134 $616,000
Q2 2023

Jul 27, 2023
BUY
$14.1 - $19.83 $423 - $594
30 Added 0.14%
21,696 $348,000
Q1 2023

May 02, 2023
SELL
$9.09 - $19.45 $44,768 - $95,791
-4,925 Reduced 18.52%
21,666 $377,000
Q4 2022

Feb 10, 2023
BUY
$6.45 - $12.07 $774 - $1,448
120 Added 0.45%
26,591 $245,000
Q4 2022

Feb 09, 2023
SELL
$6.45 - $12.07 $257,135 - $481,182
-39,866 Reduced 60.1%
26,471 $244,000
Q3 2022

Nov 02, 2022
SELL
$7.86 - $12.91 $3,301 - $5,422
-420 Reduced 0.63%
66,337 $571,000
Q2 2022

Aug 01, 2022
SELL
$7.06 - $13.97 $198,315 - $392,417
-28,090 Reduced 29.62%
66,757 $544,000
Q1 2022

May 04, 2022
BUY
$12.15 - $35.28 $141,960 - $412,211
11,684 Added 14.05%
94,847 $896,000
Q4 2021

Feb 07, 2022
SELL
$30.49 - $48.49 $14.1 Million - $22.4 Million
-462,445 Reduced 84.76%
83,163 $2.84 Million
Q3 2021

Nov 02, 2021
BUY
$41.66 - $52.52 $5.08 Million - $6.41 Million
122,020 Added 28.81%
545,608 $26.3 Million
Q2 2021

Aug 03, 2021
BUY
$36.62 - $51.69 $10.9 Million - $15.4 Million
297,845 Added 236.87%
423,588 $19.1 Million
Q1 2021

May 04, 2021
BUY
$41.56 - $59.88 $1.37 Million - $1.97 Million
32,924 Added 35.47%
125,743 $6.06 Million
Q4 2020

Feb 01, 2021
SELL
$36.08 - $56.47 $162,648 - $254,566
-4,508 Reduced 4.63%
92,819 $5 Million
Q3 2020

Nov 09, 2020
SELL
$33.26 - $40.48 $44,668 - $54,364
-1,343 Reduced 1.36%
97,327 $3.59 Million
Q2 2020

Aug 07, 2020
SELL
$24.21 - $31.02 $4.26 Million - $5.45 Million
-175,837 Reduced 64.06%
98,670 $3.06 Million
Q1 2020

May 04, 2020
SELL
$20.5 - $34.53 $122,754 - $206,765
-5,988 Reduced 2.13%
274,507 $7.58 Million
Q4 2019

Feb 06, 2020
BUY
$18.96 - $29.84 $15,471 - $24,349
816 Added 0.29%
280,495 $8.2 Million
Q4 2019

Feb 04, 2020
SELL
$18.96 - $29.84 $677,687 - $1.07 Million
-35,743 Reduced 11.33%
279,679 $9.01 Million
Q3 2019

Nov 12, 2019
BUY
$19.12 - $26.24 $4.89 Million - $6.71 Million
255,662 Added 427.81%
315,422 $6.03 Million
Q1 2019

May 03, 2019
SELL
$12.14 - $20.46 $215,970 - $363,983
-17,790 Reduced 22.94%
59,760 $1.22 Million
Q4 2018

Feb 05, 2019
SELL
$11.24 - $18.5 $1.31 Million - $2.16 Million
-116,550 Reduced 60.05%
77,550 $978,000
Q3 2018

Nov 01, 2018
BUY
$12.5 - $15.38 $2.43 Million - $2.99 Million
194,100 New
194,100 $2.98 Million

Others Institutions Holding NEO

# of Institutions
291
Shares Held
131M
Call Options Held
1.3M
Put Options Held
395K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.3B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email